Missed Out on Eli Lilly and Novo Nordisk? This Could Be the Next Big Weight Loss Stock.
Eli Lilly and Novo Nordisk have been among the hottest healthcare stocks to own over the past few years. Since 2021, shares of the two companies are up more than 260%, with Eli Lilly now becoming the most valuable publicly traded healthcare company in the world.
Eli Lilly's and Novo Nordisk's diabetes and weight loss treatments have grown in popularity as they have helped patients achieve significant weight loss, and that has made investors bullish on the long-term prospects for these stocks.
But the anti-obesity market could be worth more than $100 billion by 2030, according to estimates from Goldman Sachs. There's room for more than just a couple of effective weight loss treatments, and while Eli Lilly and Novo Nordisk may be the early winners, that doesn't mean it's too late to invest in the industry.
Source Fool.com
